{"pmid":32452905,"title":"Emergence from the COVID-19 Pandemic and the Care of Chronic Pain: Guidance for the Interventionalist.","text":["Emergence from the COVID-19 Pandemic and the Care of Chronic Pain: Guidance for the Interventionalist.","INTRODUCTION: The current coronavirus disease (COVID-19) pandemic led to a significant disruption in the care of pain from chronic and subacute conditions. The impact of this cessation of pain treatment may have unintended consequences of increased pain, reduced function, increased reliance on opioid medications and potential increased morbidity, due to the systemic impact of untreated disease burden. This may include decreased mobility, reduction in overall health status and increase of opioid use with the associated risks. METHODS: The article is the work of the American Society of Pain and Neuroscience (ASPN) COVID-19 Task Force to evaluate the policies set forth by federal, state, and local agencies to reduce or eliminate elective procedures for those patients with pain from spine, nerve and joint disease. The impact of these decisions, which were needed to reduce the spread of the pandemic, led to a delay in care for many patients. We hence review an emergence plan to reinitiate this pain-related care. The goal is to outline a path to work with federal, state, and local authorities to combat the spread of the pandemic and minimize the deleterious impact of pain and suffering on our chronic pain patients. RESULT: The paper sets forth a strategy for the interventional pain centers to reemerge from the current pandemic and to set a course for future events.","Anesth Analg","Deer, Timothy","Sayed, Dawood","Pope, Jason","Chakravarthy, Krishnan","Petersen, Erika","Moeschler, Susan M","Abd-Elsayed, Alaa","Amirdelfan, Kasra","Mekhail, Nagy","32452905"],"abstract":["INTRODUCTION: The current coronavirus disease (COVID-19) pandemic led to a significant disruption in the care of pain from chronic and subacute conditions. The impact of this cessation of pain treatment may have unintended consequences of increased pain, reduced function, increased reliance on opioid medications and potential increased morbidity, due to the systemic impact of untreated disease burden. This may include decreased mobility, reduction in overall health status and increase of opioid use with the associated risks. METHODS: The article is the work of the American Society of Pain and Neuroscience (ASPN) COVID-19 Task Force to evaluate the policies set forth by federal, state, and local agencies to reduce or eliminate elective procedures for those patients with pain from spine, nerve and joint disease. The impact of these decisions, which were needed to reduce the spread of the pandemic, led to a delay in care for many patients. We hence review an emergence plan to reinitiate this pain-related care. The goal is to outline a path to work with federal, state, and local authorities to combat the spread of the pandemic and minimize the deleterious impact of pain and suffering on our chronic pain patients. RESULT: The paper sets forth a strategy for the interventional pain centers to reemerge from the current pandemic and to set a course for future events."],"journal":"Anesth Analg","authors":["Deer, Timothy","Sayed, Dawood","Pope, Jason","Chakravarthy, Krishnan","Petersen, Erika","Moeschler, Susan M","Abd-Elsayed, Alaa","Amirdelfan, Kasra","Mekhail, Nagy"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32452905","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1213/ANE.0000000000005000","locations":["Interventionalist"],"topics":["Prevention"],"weight":1,"_version_":1667881798495895552,"score":9.490897,"similar":[{"pmid":32259288,"title":"Caring for patients with pain during the COVID-19 pandemic: consensus recommendations from an international expert panel.","text":["Caring for patients with pain during the COVID-19 pandemic: consensus recommendations from an international expert panel.","Chronic pain causes significant suffering, limitation of daily activities and reduced quality of life. Infection from COVID-19 is responsible for an ongoing pandemic that causes severe acute respiratory syndrome, leading to systemic complications and death. Led by the World Health Organization, healthcare systems across the world are engaged in limiting the spread of infection. As a result, all elective surgical procedures, outpatient procedures and patient visits, including pain management services, have been postponed or cancelled. This has affected the care of chronic pain patients. Most are elderly with multiple comorbidities, which puts them at risk of COVID-19 infection. Important considerations that need to be recognised during this pandemic for chronic pain patients include: ensuring continuity of care and pain medications, especially opioids; use of telemedicine; maintaining biopsychosocial management; use of anti-inflammatory drugs; use of steroids; and prioritising necessary procedural visits. There are no guidelines to inform physicians and healthcare providers engaged in caring for patients with pain during this period of crisis. We assembled an expert panel of pain physicians, psychologists and researchers from North America and Europe to formulate recommendations to guide practice. As the COVID-19 situation continues to evolve rapidly, these recommendations are based on the best available evidence and expert opinion at this present time and may need adapting to local workplace policies.","Anaesthesia","Shanthanna, H","Strand, N H","Provenzano, D A","Lobo, C A","Eldabe, S","Bhatia, A","Wegener, J","Curtis, K","Cohen, S P","Narouze, S","32259288"],"abstract":["Chronic pain causes significant suffering, limitation of daily activities and reduced quality of life. Infection from COVID-19 is responsible for an ongoing pandemic that causes severe acute respiratory syndrome, leading to systemic complications and death. Led by the World Health Organization, healthcare systems across the world are engaged in limiting the spread of infection. As a result, all elective surgical procedures, outpatient procedures and patient visits, including pain management services, have been postponed or cancelled. This has affected the care of chronic pain patients. Most are elderly with multiple comorbidities, which puts them at risk of COVID-19 infection. Important considerations that need to be recognised during this pandemic for chronic pain patients include: ensuring continuity of care and pain medications, especially opioids; use of telemedicine; maintaining biopsychosocial management; use of anti-inflammatory drugs; use of steroids; and prioritising necessary procedural visits. There are no guidelines to inform physicians and healthcare providers engaged in caring for patients with pain during this period of crisis. We assembled an expert panel of pain physicians, psychologists and researchers from North America and Europe to formulate recommendations to guide practice. As the COVID-19 situation continues to evolve rapidly, these recommendations are based on the best available evidence and expert opinion at this present time and may need adapting to local workplace policies."],"journal":"Anaesthesia","authors":["Shanthanna, H","Strand, N H","Provenzano, D A","Lobo, C A","Eldabe, S","Bhatia, A","Wegener, J","Curtis, K","Cohen, S P","Narouze, S"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32259288","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1111/anae.15076","keywords":["covid-19","chronic pain","opioids","recommendations","steroids"],"e_drugs":["Steroids"],"topics":["Prevention"],"weight":1,"_version_":1666138493172056066,"score":328.0905},{"pmid":32259247,"pmcid":"PMC7184417","title":"Pain Management Best Practices from Multispecialty Organizations during the COVID-19 Pandemic and Public Health Crises.","text":["Pain Management Best Practices from Multispecialty Organizations during the COVID-19 Pandemic and Public Health Crises.","BACKGROUND: It is nearly impossible to overestimate the burden of chronic pain, which is associated with enormous personal and socioeconomic costs. Chronic pain is the leading cause of disability in the world, is associated with multiple psychiatric co-morbidities, and has been causally linked for the opioid crisis. Access to pain treatment has been called a fundamental human right by numerous organizations. The current COVID-19 pandemic has strained medical resources, creating a dilemma for physicians charged with a responsibility to limit spread of the contagion, and their responsibility to treat the patients they are entrusted to care for. METHODS: To address these issues, an expert panel was convened that included pain management experts from the military, Veterans Health Administration, and academia. Endorsement from stakeholder societies was sought upon completion of the document, with a 1-week suspense period. RESULTS: In these guidelines, we provide a framework for pain practitioners and institutions to balance the often-conflicting goals of risk mitigation for health care providers, risk mitigation for patients, conservation of resources, and access to pain management services. Specific issues discussed include general and interventional-specific risk mitigation, patient flow issues and staffing plans, telemedicine options, triaging recommendations, strategies to reduce psychological sequelae in health care providers, and resource utilization. CONCLUSIONS: The COVID-19 public health crisis has strained health care systems, creating a conundrum for patients, pain medicine practitioners, hospital leaders, and regulatory officials. Although this document provides a framework for pain management services, systems-wide and individual decisions must take into account clinical considerations, regional health conditions, government and hospital directives, resource availability, the welfare of health care providers. Video-Abstract link: https://vimeo.com/houpla/review/403517991/6a15e5ff38.","Pain Med","Cohen, Steven P","Baber, Zafeer B","Buvanendran, Asokumar","McLean, L T C Brian C","Chen, Yian","Hooten, W Michael","Laker, Scott R","Wasan, W Ajay D","Kennedy, David J","Sandbrink, Friedhelm","King, L T C Scott A","Fowler, C D R Ian M","Stojanovic, Milan P","Hayek, Salim M","Phillips, C D R Christopher R","32259247"],"abstract":["BACKGROUND: It is nearly impossible to overestimate the burden of chronic pain, which is associated with enormous personal and socioeconomic costs. Chronic pain is the leading cause of disability in the world, is associated with multiple psychiatric co-morbidities, and has been causally linked for the opioid crisis. Access to pain treatment has been called a fundamental human right by numerous organizations. The current COVID-19 pandemic has strained medical resources, creating a dilemma for physicians charged with a responsibility to limit spread of the contagion, and their responsibility to treat the patients they are entrusted to care for. METHODS: To address these issues, an expert panel was convened that included pain management experts from the military, Veterans Health Administration, and academia. Endorsement from stakeholder societies was sought upon completion of the document, with a 1-week suspense period. RESULTS: In these guidelines, we provide a framework for pain practitioners and institutions to balance the often-conflicting goals of risk mitigation for health care providers, risk mitigation for patients, conservation of resources, and access to pain management services. Specific issues discussed include general and interventional-specific risk mitigation, patient flow issues and staffing plans, telemedicine options, triaging recommendations, strategies to reduce psychological sequelae in health care providers, and resource utilization. CONCLUSIONS: The COVID-19 public health crisis has strained health care systems, creating a conundrum for patients, pain medicine practitioners, hospital leaders, and regulatory officials. Although this document provides a framework for pain management services, systems-wide and individual decisions must take into account clinical considerations, regional health conditions, government and hospital directives, resource availability, the welfare of health care providers. Video-Abstract link: https://vimeo.com/houpla/review/403517991/6a15e5ff38."],"journal":"Pain Med","authors":["Cohen, Steven P","Baber, Zafeer B","Buvanendran, Asokumar","McLean, L T C Brian C","Chen, Yian","Hooten, W Michael","Laker, Scott R","Wasan, W Ajay D","Kennedy, David J","Sandbrink, Friedhelm","King, L T C Scott A","Fowler, C D R Ian M","Stojanovic, Milan P","Hayek, Salim M","Phillips, C D R Christopher R"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32259247","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1093/pm/pnaa127","topics":["Prevention"],"weight":1,"_version_":1666138493182541825,"score":321.72998},{"pmid":32447087,"title":"Exposure to greenspaces could reduce the high global burden of pain.","text":["Exposure to greenspaces could reduce the high global burden of pain.","Painful conditions are among the leading causes of years lived with disability, and may increase following the coronavirus pandemic, which has led to temporary closure of some healthcare services for people with chronic pain. To reduce this burden, novel, cost-effective and accessible interventions are required. We propose that greenspace exposure may be one such intervention. Drawing on evidence from neuroscience, physiology, microbiology, and psychology, we articulate how and why exposure to greenspaces could improve pain outcomes and reduce the high global burden of pain. Greenspace exposure potentially provides opportunities to benefit from known or proposed health-enhancing components of nature, such as environmental microbiomes, phytoncides, negative air ions, sunlight, and the sights and sounds of nature itself. We review the established and potential links between these specific exposures and pain outcomes. While further research is required to determine possible causal links between greenspace exposure and pain outcomes, we suggest that there is already sufficient evidence to help reduce the global burden of pain by improving access and exposure to quality greenspaces.","Environ Res","Stanhope, Jessica","Breed, Martin F","Weinstein, Philip","32447087"],"abstract":["Painful conditions are among the leading causes of years lived with disability, and may increase following the coronavirus pandemic, which has led to temporary closure of some healthcare services for people with chronic pain. To reduce this burden, novel, cost-effective and accessible interventions are required. We propose that greenspace exposure may be one such intervention. Drawing on evidence from neuroscience, physiology, microbiology, and psychology, we articulate how and why exposure to greenspaces could improve pain outcomes and reduce the high global burden of pain. Greenspace exposure potentially provides opportunities to benefit from known or proposed health-enhancing components of nature, such as environmental microbiomes, phytoncides, negative air ions, sunlight, and the sights and sounds of nature itself. We review the established and potential links between these specific exposures and pain outcomes. While further research is required to determine possible causal links between greenspace exposure and pain outcomes, we suggest that there is already sufficient evidence to help reduce the global burden of pain by improving access and exposure to quality greenspaces."],"journal":"Environ Res","authors":["Stanhope, Jessica","Breed, Martin F","Weinstein, Philip"],"date":"2020-05-25T11:00:00Z","year":2020,"_id":"32447087","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.envres.2020.109641","keywords":["greenspace","microbiome","pain","public health"],"topics":["Prevention"],"weight":1,"_version_":1667698385992286209,"score":300.24213},{"pmid":32476041,"title":"Capacity changes in German certified chest pain units during COVID-19 outbreak response.","text":["Capacity changes in German certified chest pain units during COVID-19 outbreak response.","BACKGROUND: We sought to determine structure and changes in organisation and bed capacities of certified German chest pain units (CPU) in response to the emergency plan set-up as a response to the SARS-CoV-2 pandemic. METHODS AND RESULTS: The study was conducted in the form of a standardised telephone interview survey in certified German CPUs. Analyses comprised the overall setting of the CPU, bed capacities, possibilities for ventilation, possible changes in organisation and resources, chest pain patient admittance, overall availability of CPUs and bail-out strategies. The response rate was 91%. Nationwide, CPU bed capacities decreased by 3% in the early phase of COVID-19 pandemic response, exhibiting differences within and between the federal states. Pre-pandemic and pandemic bed capacities stayed below 1 CPU bed per 50,000 inhabitants. 97% of CPUs were affected by internal reorganisation pandemic plans at variable extent. While we observed a decrease of CPU beds within an emergency room (ER) set-up and on intermediate care units (ICU), beds in units being separated from ER and ICU were even increased in numbers. CONCLUSIONS: Certified German CPUs are able to maintain adequate coverage for chest pain patients in COVID-19 pandemic despite structural changes. However, at this time, it appears important to add operating procedures during pandemic outbreaks to the certification criteria of forthcoming guidelines either at the individual CPU level or more centrally steered by the German Cardiac Society or the European Society of Cardiology.","Clin Res Cardiol","Settelmeier, Stephan","Rassaf, Tienush","Giannitsis, Evangelos","Munzel, Thomas","Breuckmann, Frank","32476041"],"abstract":["BACKGROUND: We sought to determine structure and changes in organisation and bed capacities of certified German chest pain units (CPU) in response to the emergency plan set-up as a response to the SARS-CoV-2 pandemic. METHODS AND RESULTS: The study was conducted in the form of a standardised telephone interview survey in certified German CPUs. Analyses comprised the overall setting of the CPU, bed capacities, possibilities for ventilation, possible changes in organisation and resources, chest pain patient admittance, overall availability of CPUs and bail-out strategies. The response rate was 91%. Nationwide, CPU bed capacities decreased by 3% in the early phase of COVID-19 pandemic response, exhibiting differences within and between the federal states. Pre-pandemic and pandemic bed capacities stayed below 1 CPU bed per 50,000 inhabitants. 97% of CPUs were affected by internal reorganisation pandemic plans at variable extent. While we observed a decrease of CPU beds within an emergency room (ER) set-up and on intermediate care units (ICU), beds in units being separated from ER and ICU were even increased in numbers. CONCLUSIONS: Certified German CPUs are able to maintain adequate coverage for chest pain patients in COVID-19 pandemic despite structural changes. However, at this time, it appears important to add operating procedures during pandemic outbreaks to the certification criteria of forthcoming guidelines either at the individual CPU level or more centrally steered by the German Cardiac Society or the European Society of Cardiology."],"journal":"Clin Res Cardiol","authors":["Settelmeier, Stephan","Rassaf, Tienush","Giannitsis, Evangelos","Munzel, Thomas","Breuckmann, Frank"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32476041","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1007/s00392-020-01676-z","keywords":["covid-19","capacity","chest pain unit","germany","pandemic"],"locations":["German","German","Certified German","German"],"countries":["Germany"],"countries_codes":["DEU|Germany"],"topics":["Prevention"],"weight":1,"_version_":1668437834900439040,"score":247.16165},{"pmid":32426576,"pmcid":"PMC7229474","title":"Laparoscopic surgery for benign adnexal conditions under spinal anaesthesia: Towards a multidisciplinary minimally invasive approach.","text":["Laparoscopic surgery for benign adnexal conditions under spinal anaesthesia: Towards a multidisciplinary minimally invasive approach.","Background: Laparoscopic gynaecological surgery is commonly performed under general anaesthesia with endotracheal intubation. In general surgery, locoregional anaesthesia was applied to laparoscopic procedures, increasing minimally invasive surgery advantages. Aims: To assess and compare postoperative pain after laparoscopic adnexal procedures for benign conditions under spinal anaesthesia (SA) versus general anaesthesia (GA). Furthermore, anaesthesiologic, surgical and clinical data were evaluated in both groups. Materials and Methods: This is a prospective cohort study performed in a tertiary level referral centre for minimally invasive gynaecological surgery (Gynaecology and Human Reproduction Physiopathology, University of Bologna). Women scheduled for adnexal laparoscopic surgery for benign conditions between February and May 2019 were assigned to receive either SA or GA with endotracheal intubation. A sample size of 13 women per group was needed to detect a 2-point difference in pain scores. Main findings: 13 women were enrolled in the SA arm, 15 in the GA arm. In the SA cohort, the most common intraoperative adverse event was shoulder pain, reported by 3/12 women. At 1, 8, 12, 24 and 48 hours after surgery pain was significantly lower in the SA arm (p < .05). Patients submitted to SA experienced no need for opioid drugs administration, unlike those receiving GA. Patients' mobilization and return of bowel function were noted significantly earlier in the SA group (p < .05). Conclusions: SA is a feasible, safe and effective anaesthesiologic technique for laparoscopic gynaecological procedures for benign conditions, allowing a better control of postoperative pain. Women undergoing SA achieve earlier mobilization and bowel canalization. During the Covid-19 pandemics, SA could be useful in reducing the need for invasive procedures on respiratory tract.","J Gynecol Obstet Hum Reprod","Raimondo, Diego","Borghese, Giulia","Mastronardi, Manuela","Mabrouk, Mohamed","Salucci, Paolo","Lambertini, Agnese","Casadio, Paolo","Tonini, Claudia","Meriggiola, Maria Cristina","Arena, Alessandro","Tarozzi, Giulia","Seracchioli, Renato","32426576"],"abstract":["Background: Laparoscopic gynaecological surgery is commonly performed under general anaesthesia with endotracheal intubation. In general surgery, locoregional anaesthesia was applied to laparoscopic procedures, increasing minimally invasive surgery advantages. Aims: To assess and compare postoperative pain after laparoscopic adnexal procedures for benign conditions under spinal anaesthesia (SA) versus general anaesthesia (GA). Furthermore, anaesthesiologic, surgical and clinical data were evaluated in both groups. Materials and Methods: This is a prospective cohort study performed in a tertiary level referral centre for minimally invasive gynaecological surgery (Gynaecology and Human Reproduction Physiopathology, University of Bologna). Women scheduled for adnexal laparoscopic surgery for benign conditions between February and May 2019 were assigned to receive either SA or GA with endotracheal intubation. A sample size of 13 women per group was needed to detect a 2-point difference in pain scores. Main findings: 13 women were enrolled in the SA arm, 15 in the GA arm. In the SA cohort, the most common intraoperative adverse event was shoulder pain, reported by 3/12 women. At 1, 8, 12, 24 and 48 hours after surgery pain was significantly lower in the SA arm (p < .05). Patients submitted to SA experienced no need for opioid drugs administration, unlike those receiving GA. Patients' mobilization and return of bowel function were noted significantly earlier in the SA group (p < .05). Conclusions: SA is a feasible, safe and effective anaesthesiologic technique for laparoscopic gynaecological procedures for benign conditions, allowing a better control of postoperative pain. Women undergoing SA achieve earlier mobilization and bowel canalization. During the Covid-19 pandemics, SA could be useful in reducing the need for invasive procedures on respiratory tract."],"journal":"J Gynecol Obstet Hum Reprod","authors":["Raimondo, Diego","Borghese, Giulia","Mastronardi, Manuela","Mabrouk, Mohamed","Salucci, Paolo","Lambertini, Agnese","Casadio, Paolo","Tonini, Claudia","Meriggiola, Maria Cristina","Arena, Alessandro","Tarozzi, Giulia","Seracchioli, Renato"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32426576","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.jogoh.2020.101813","keywords":["asa, american society of anesthesiologist","bmi, body mass index","etco2, end-tidal co2","ga, general anaesthesia","lra, locoregional anaesthesia","nsaid, non-steroid anti-inflammatory drugs","ponv, postoperative nausea and vomiting","sa, spinal anaesthesia","vnrs, verbal numerical rating scale","general anaesthesia","laparoscopy","postoperative pain","postoperative recovery","spinal anaesthesia"],"topics":["Prevention"],"weight":1,"_version_":1667252838045057024,"score":239.05861}]}